• Home >
  • Sector

    • API

    Active Pharmaceutical Ingredients (APIs) are combined with excipients (inactive substances) to make drugs.  Here you will find content about the development, manufacturing, analysis and regulation of pharmaceutical APIs.

    Articles

    Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.
    Screen Shot 2023 09 06 At 11 17 20 Am
    Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
    PM2208-HERO-575x327-Development
    A new biomanufacturing era demands that suppliers and manufacturers partner to efficiently bring new therapies to market
    final-may
    Supply chain challenges and industry trends are spurring new business strategies

    News

    india
    The world's leader of generic drug production looks towards new horizons in pharma
    PM2101-Predictions-Logo
    In many ways, the beginning of 2021 isn’t just one of the most welcome New Years of the modern era — it could also be a turning point between the pre-COVID and post-COVID worlds...
    powder
    Leveraging new powder technologies to manufacture personalized medicines
    shutterstock-1734037067
    The government wants to reshore generics, but the drug industry isn’t celebrating
    lab
    Technologies accelerating the verification process for raw materials
    PM2009-HERO-880x500-CoverStory2
    Inside the movement to put generic drug production back on America's shores
    ships
    The need to explore the diversification of U.S. pharmaceutical supply chains and the feasibility of relocation has never been higher.